Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C07D-403/06
C07C-059/265
A61K-031/4025
C07C-059/255
출원번호
US-0354832
(2016-11-17)
등록번호
US-9981949
(2018-05-29)
발명자
/ 주소
Akireddy, Srinivasa Rao
Bhatti, Balwinder Singh
Cuthbertson, Timothy J.
Dull, Gary Maurice
Miller, Craig Harrison
Mitchener, Jr., Joseph Pike
Munoz, Julio A.
Otten, Pieter Albert
출원인 / 주소
Oyster Point Pharma, Inc.
대리인 / 주소
Cooley LLP
인용정보
피인용 횟수 :
0인용 특허 :
21
초록
The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.
대표청구항▼
1. A method for manufacture of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine comprising: (a) treating compound 1 with methanesulfonyl chloride to give compound 2 (b) treating compound 2 with diethylmalonate and a base selected from the group consisting of potassium tert-butoxide and sodium ethoxide
1. A method for manufacture of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine comprising: (a) treating compound 1 with methanesulfonyl chloride to give compound 2 (b) treating compound 2 with diethylmalonate and a base selected from the group consisting of potassium tert-butoxide and sodium ethoxide to give compound 3 (c) hydrolyzing compound 3 to give compound 4 (d) decarboxylating compound 4 to give compound 5 (e) reducing compound 5 to give compound 6 (f) treating compound 6 with methanesulfonyl chloride to give compound 7 (g) reacting compound 7 with sodium iodide to give compound 8 and(h) treating compound 8 with potassium tert-butoxide to give compound 9, tert-butyl (R)-3-vinylpyrrolidine-1-carboxylate, 2. The method of claim 1, wherein step (b) does not comprise column chromatography. 3. The method of claim 1, wherein step (e) does not comprise column chromatography. 4. The method of claim 1, wherein step (h) does not comprise column chromatography. 5. The method of claim 1, wherein the hydrolysis of compound 3 is performed by reaction with potassium hydroxide. 6. The method of claim 1, wherein the decarboxylation of compound 4 is performed in a solvent with heating, and wherein the solvent is selected from the group consisting of water, ethanol, tetrahydrofuran, dimethylformamide, dimethylacetamide, 1,2-dimethoxyethane, dioxane, 1-methyl-2-pyrrolidinone, dimethylsulfoxide, toluene, and mixtures thereof. 7. The method of claim 6, wherein the solvent for the decarboxylation is selected from 1-methyl-2-pyrrolidinone, dimethylsulfoxide, toluene, and mixtures thereof. 8. The method of claim 1, wherein the reduction of compound 5 is performed by reaction with a reagent selected from borane, diborane, borane-tetrahydrofuran complex, borane-dimethyl ether complex, and borane-dimethylsulfide complex. 9. The method of claim 8, wherein the reduction of compound 5 is performed by reaction with borane-tetrahydrofuran complex. 10. The method of claim 1, further comprising (i) reacting compound 9 with 5-bromo-pyrimidine to give compound 10 11. The method of claim 10, wherein the reaction of step (i) is a palladium-catalyzed reaction. 12. The method of claim 10, further comprising (j) deprotecting compound 10 to give compound 11 13. The method of claim 12, wherein the deprotection reaction of step (j) is performed with a reagent selected from trifluoroacetic acid, hydrochloric acid, and sulfuric acid. 14. A method for manufacture of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-citrate comprising: (i) mixing the free base, or a solution of the free base, of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine in a first solvent with citric acid in pure form or as a solution of the citric acid in a first solvent to form a citrate salt solution, wherein the first solvent is selected from the group consisting of ethanol, methanol, isopropyl alcohol, isopropyl acetate, acetone, ethyl acetate, toluene, water, methyl ethyl ketone, methyl isobutyl ketone, tert-butyl methyl ether, tetrahydrofuran, dichloromethane, n-heptane, and acetonitrile;(ii) (a) cooling the resulting citrate salt solution to cause precipitation; or(ii) (b) adding a second solvent selected from the group consisting of ethanol, methanol, isopropyl alcohol, isopropyl acetate, acetone, ethyl acetate, toluene, water, methyl ethyl ketone, methyl isobutyl ketone, tert-butyl methyl ether, tetrahydrofuran, dichloromethane, n-heptane, and acetonitrile to cause precipitation; or(ii) (c) evaporating the first solvent and adding a second solvent selected from the group consisting of ethanol, methanol, isopropyl alcohol, isopropyl acetate, acetone, ethyl acetate, toluene, water, methyl ethyl ketone, methyl isobutyl ketone, tert-butyl methyl ether, tetrahydrofuran, dichloromethane, n-heptane, and acetonitrile, and repeating either step (ii) (a) or (ii) (b); and(iii) filtering to collect the (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-citrate.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (21)
Turconi Marco (Voghera ITX) Micheletti Rosamarie (Milan ITX) Schiavi Giovanni B. (Asola ITX) Donetti Arturo (Milan ITX) Sagrada Angelo (Milan ITX) Doods Henri N. (Warthausen DEX), Benzofused-N-containing heterocycle derivatives.
Peters David (Long Valley NJ) Denick ; Jr. John (Newton NJ) Talwar Anil K. (Long Valley NJ), Magnesium trisilicate suitable for preparation of medicament adsorbates of antinauseants.
Bencherif Merouane ; Lippiello Patrick Michael, Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characteriz.
Smith Carr J. (5548 Moravian Heights La. Clemmons NC 27012) Lippiello Patrick M. (1233 Arboretum Dr. Lewisville NC 27023) Bencherif Merouane (5437-B Countryside Dr. Winston-Salem NC 27105) Caldwell W, Pharmaceutical compositions for prevention and treatment of ulcerative colitis.
Bencherif Merouane (5437-B Countryside Dr. Winston-Salem NC 27105) Caldwell William S. (1270 Yorkshire Rd. Winston-Salem NC 27106) Dull Gary M. (1175 Sequoia Dr. Lewisville NC 27023) Lippiello Patric, Pharmaceutical compositions for the treatment of central nervous system disorders.
Dull Gary M. (1175 Sequoia Dr. Lewisville NC 27023) Caldwell William S. (1270 Yorkshire Rd. Winston-Salem NC 27106), Pyrimidinyl or Pyridinyl alkenyl amine compounds.
Elmaleh David R. ; Madras Bertha K. ; Meltzer Peter ; Hanson Robert N., Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neuro.
Akireddy, Srinivasa Rao; Bhatti, Balwinder Singh; Cuthbertson, Timothy J.; Dull, Gary Maurice; Miller, Craig Harrison; Mitchener, Jr., Joseph Pike; Munoz, Julio A.; Otten, Pieter Albert, Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine.
Akireddy, Srinivasa Rao; Bhatti, Balwinder Singh; Cuthbertson, Timothy J.; Dull, Gary Maurice; Miller, Craig Harrison; Mitchener, Joseph Pike; Munoz, Julio A.; Otten, Pieter Albert, Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.